Cover Image
市場調查報告書

切片設備:醫療設備的開發平台評估

Biopsy Devices - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 408123
出版日期 內容資訊 英文 234 Pages
訂單完成後即時交付
價格
Back to Top
切片設備:醫療設備的開發平台評估 Biopsy Devices - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月01日 內容資訊: 英文 234 Pages
簡介

與 本報告提供全球切片設備的市場上主要開發中產品 (醫療設備) 及其臨床實驗的進展調查,提供產品特性比較分析 (臨床實驗的各進展階段) ,再彙整主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 切片設備概要

第3章 現在臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各領域
  • 開發中產品:各法規途徑
  • 開發中產品:各估計認證時期
  • 現在進行中的臨床實驗

第4章 切片設備:各企業現在臨床實驗中的開發中產品

  • 切片設備的企業:各臨床實驗階段的開發中產品
  • 切片設備:各臨床實驗階段的開發中產品

第5章 切片設備的企業·產品概要

  • Acoustic MedSystems, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Actuated Medical, Inc.
  • Arch Medical Devices Ltd
  • Boston University
  • C. R. Bard Inc
  • Carlos III Health Institute
  • CleveX, Inc.
  • Columbia University
  • Control Medical Technology, LLC
  • Crux Medical Innovations
  • CuraMedical BV
  • Dartmouth College
  • Dune Medical Devices Ltd.
  • Emory University
  • Endomagnetics Inc.
  • EP Global Communications, Inc.
  • Gamma Medica Inc
  • Hologic Inc
  • iCAD Inc
  • Indian Institute of Technology Bombay
  • Indio Labs Pvt Ltd
  • Innobreeze Communication Technologies Private Limited
  • Institute of Cancer Research
  • Intelligent Fiber Optic Systems Corporation
  • John Hopkins University
  • Massachusetts General Hospital
  • Mayo Clinic US
  • Merit Medical Systems, Inc.
  • MI4 Spine, LLC
  • MRI Interventions Inc
  • NeoDynamics AB
  • Precision Biopsy Llc
  • Quality ElectroDynamics, LLC
  • Robopsy
  • Rutgers The State University of New Jersey
  • Sanovas Inc
  • SpectraScience, Inc.
  • Taewoong Medical Co.,Ltd.
  • The University of Queensland
  • Tufts University
  • UC Care Ltd.
  • University of California Los Angeles
  • University of California San Diego
  • University of California San Francisco
  • University of Florida
  • University of Leicester
  • University of Louisville
  • University of Michigan
  • University of Minnesota
  • University of Missouri
  • University of Texas at Austin
  • University of Texas Health Science Center at San Antonio
  • University of Washington
  • Vanderbilt University
  • Vascular BioSciences
  • Veran Medical Technologies Inc
  • Verisante Technology Inc
  • VitruMed Inc.
  • Yale University
  • ZAMAR S.r.l.

第6章 切片設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0418EPD

GlobalData's Medical Devices sector report, "Biopsy Devices - Medical Devices Pipeline Assessment, 2017" provides an overview of Biopsy Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Biopsy Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Biopsy Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Biopsy Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Biopsy Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 13

2 Introduction 14

  • 2.1 Biopsy Devices Overview 14

3 Products under Development 16

  • 3.1 Biopsy Devices - Pipeline Products by Stage of Development 16
  • 3.2 Biopsy Devices - Pipeline Products by Segment 17
  • 3.3 Biopsy Devices - Pipeline Products by Territory 18
  • 3.4 Biopsy Devices - Pipeline Products by Regulatory Path 19
  • 3.5 Biopsy Devices - Pipeline Products by Estimated Approval Date 20
  • 3.6 Biopsy Devices - Ongoing Clinical Trials 21

4 Biopsy Devices - Pipeline Products under Development by Companies 22

  • 4.1 Biopsy Devices Companies - Pipeline Products by Stage of Development 22
  • 4.2 Biopsy Devices - Pipeline Products by Stage of Development 25

5 Biopsy Devices Companies and Product Overview 28

  • 5.1 Actuated Medical Inc Company Overview 28
    • 5.1.1 Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • 5.2 Arch Medical Devices Ltd Company Overview 29
    • 5.2.1 Arch Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • 5.3 Boston University Company Overview 32
    • 5.3.1 Boston University Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.4 C. R. Bard Inc Company Overview 34
    • 5.4.1 C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.5 Carlos III Health Institute Company Overview 37
    • 5.5.1 Carlos III Health Institute Pipeline Products & Ongoing Clinical Trials Overview 37
  • 5.6 CleveX, Inc. Company Overview 38
    • 5.6.1 CleveX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 Columbia University Company Overview 39
    • 5.7.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.8 Control Medical Technology LLC Company Overview 41
    • 5.8.1 Control Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.9 Crux Medical Innovations Company Overview 45
    • 5.9.1 Crux Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 45
  • 5.10 CuraMedical BV Company Overview 46
    • 5.10.1 CuraMedical BV Pipeline Products & Ongoing Clinical Trials Overview 46
  • 5.11 Dartmouth College Company Overview 47
    • 5.11.1 Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 47
  • 5.12 Dune Medical Devices Ltd. Company Overview 48
    • 5.12.1 Dune Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
  • 5.13 Emory University Company Overview 49
    • 5.13.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.14 Endomagnetics Inc. Company Overview 50
    • 5.14.1 Endomagnetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • 5.15 EP Global Communications, Inc. Company Overview 53
    • 5.15.1 EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • 5.16 Gamma Medica Inc Company Overview 54
    • 5.16.1 Gamma Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • 5.17 Harvard University Company Overview 55
    • 5.17.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.18 Hologic Inc Company Overview 56
    • 5.18.1 Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • 5.19 iCAD Inc Company Overview 57
    • 5.19.1 iCAD Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.20 Icahn School of Medicine at Mount Sinai Company Overview 59
    • 5.20.1 Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 59
  • 5.21 Indian Institute of Technology Bombay Company Overview 60
    • 5.21.1 Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 60
  • 5.22 Indio Labs Pvt Ltd Company Overview 61
    • 5.22.1 Indio Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • 5.23 Innobreeze Communication Technologies Private Limited Company Overview 63
    • 5.23.1 Innobreeze Communication Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 63
  • 5.24 Institute of Cancer Research Company Overview 65
    • 5.24.1 Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview 65
  • 5.25 Intelligent Fiber Optic Systems Corporation Company Overview 66
    • 5.25.1 Intelligent Fiber Optic Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
  • 5.26 John Hopkins University Company Overview 67
    • 5.26.1 John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.27 LX Medical Corp Company Overview 70
    • 5.27.1 LX Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.28 Massachusetts General Hospital Company Overview 71
    • 5.28.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.29 Mayo Clinic US Company Overview 72
    • 5.29.1 Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 72
  • 5.30 Merit Medical Systems Inc Company Overview 73
    • 5.30.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • 5.31 MI4 Spine, LLC Company Overview 75
    • 5.31.1 MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
  • 5.32 MRI Interventions Inc Company Overview 76
    • 5.32.1 MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • 5.33 NeoDynamics AB Company Overview 77
    • 5.33.1 NeoDynamics AB Pipeline Products & Ongoing Clinical Trials Overview 77
  • 5.34 Precision Biopsy Llc Company Overview 80
    • 5.34.1 Precision Biopsy Llc Pipeline Products & Ongoing Clinical Trials Overview 80
  • 5.35 Quality ElectroDynamics, LLC Company Overview 83
    • 5.35.1 Quality ElectroDynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
  • 5.36 Rambam Health Care Campus Company Overview 84
    • 5.36.1 Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 84
  • 5.37 Robopsy Company Overview 85
    • 5.37.1 Robopsy Pipeline Products & Ongoing Clinical Trials Overview 85
  • 5.38 Rutgers The State University of New Jersey Company Overview 86
    • 5.38.1 Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 86
  • 5.39 Sanovas Inc Company Overview 87
    • 5.39.1 Sanovas Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • 5.40 SpectraScience Inc Company Overview 88
    • 5.40.1 SpectraScience Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • 5.41 Taewoong Medical Co Ltd Company Overview 96
    • 5.41.1 Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
  • 5.42 The University of Adelaide Company Overview 97
    • 5.42.1 The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 97
  • 5.43 Tufts University Company Overview 98
    • 5.43.1 Tufts University Pipeline Products & Ongoing Clinical Trials Overview 98
  • 5.44 UC Care Ltd Company Overview 99
    • 5.44.1 UC Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
  • 5.45 University of California Los Angeles Company Overview 100
    • 5.45.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 100
  • 5.46 University of California San Diego Company Overview 101
    • 5.46.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 101
  • 5.47 University of California San Francisco Company Overview 102
    • 5.47.1 University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 102
  • 5.48 University of Cambridge Company Overview 103
    • 5.48.1 University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 103
  • 5.49 University of Florida Company Overview 106
    • 5.49.1 University of Florida Pipeline Products & Ongoing Clinical Trials Overview 106
  • 5.50 University of Leicester Company Overview 107
    • 5.50.1 University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 107
  • 5.51 University of Louisville Company Overview 108
    • 5.51.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 108
  • 5.52 University of Michigan Company Overview 109
    • 5.52.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 109
  • 5.53 University of Minnesota Company Overview 112
    • 5.53.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 112
  • 5.54 University of Missouri Company Overview 114
    • 5.54.1 University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 114
  • 5.55 University of Queensland Company Overview 115
    • 5.55.1 University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 115
  • 5.56 University of Texas at Austin Company Overview 116
    • 5.56.1 University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 116
  • 5.57 University of Texas Health Science Center at San Antonio Company Overview 117
    • 5.57.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 117
  • 5.58 University of Washington Company Overview 118
    • 5.58.1 University of Washington Pipeline Products & Ongoing Clinical Trials Overview 118
  • 5.59 Vanderbilt University Company Overview 119
    • 5.59.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 119
  • 5.60 Vascular BioSciences Company Overview 120
    • 5.60.1 Vascular BioSciences Pipeline Products & Ongoing Clinical Trials Overview 120
  • 5.61 Verisante Technology Inc Company Overview 122
    • 5.61.1 Verisante Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 122
  • 5.62 VitruMed Inc. Company Overview 126
    • 5.62.1 VitruMed Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
  • 5.63 Yale University Company Overview 127
    • 5.63.1 Yale University Pipeline Products & Ongoing Clinical Trials Overview 127
  • 5.64 ZAMAR S.r.l. Company Overview 128
    • 5.64.1 ZAMAR S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 128

6 Biopsy Devices- Recent Developments 129

  • 6.1 Aug 16, 2017: Coloplast delivers satisfactory Q3 result 129
  • 6.2 Aug 10, 2017: Varian Announces New VP of Investor Relations 130
  • 6.3 Aug 09, 2017: Research Supports Compassionate New Biopsy Approach for Women's Health in Cervical Cancer Prevention 130
  • 6.4 Aug 08, 2017: iCAD Reports Second Quarter 2017 Financial Results and Announces $13 Million Credit Facility With Silicon Valley Bank 130
  • 6.5 Aug 07, 2017: Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform 132
  • 6.6 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 133
  • 6.7 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 134
  • 6.8 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017 134
  • 6.9 Aug 01, 2017: Physicians Evaluate New Device to Test for Cervical Cancer 136
  • 6.10 Aug 01, 2017: MRI Interventions Reports 79% Revenue Increase and Record Treatments in Second Quarter 2017 137
  • 6.11 Jul 27, 2017: Stryker reports second quarter 2017 results 139
  • 6.12 Jul 27, 2017: Boston Scientific Announces Results for Second Quarter 2017 140
  • 6.13 Jul 26, 2017: Varian Medical Systems Reports Third Quarter Fiscal Year 2017 Results Highlighting Growth in Backlog and Improvements in both Gross Margin and Working Capital 142
  • 6.14 Jul 26, 2017: Merit Medical Reports Record Revenue and Non-GAAP Net Income for Second Quarter 2017, Raises 2017 Guidance and Gives Preliminary 2018-2019 Guidance 143
  • 6.15 Jul 11, 2017: MRI Interventions Announces Record Second Quarter ClearPoint System Procedures, And a 79% Year-Over-Year Revenue Increase 144
  • 6.16 Jul 11, 2017: Galen Partners Completes Majority Recapitalization of CDx Diagnostics 145
  • 6.17 Jul 03, 2017: Pioneering Prostate Biopsy Device Awarded £789K NIHR i4i Product Development Award 146
  • 6.18 Jun 27, 2017: Boston Scientific Outlines Strategy for Sustained Growth at 2017 Investor Day 146
  • 6.19 Jun 19, 2017: Sanovas Prepares for Global Expansion by Creating Innovation Center and Venture Capital Fund in China 148
  • 6.20 Jun 14, 2017: Following the US, Cellect Receives Russian Patent Covering Any Device and Method Using Cellect's Flagship Technology - the ApoGraft 149
  • 6.21 May 26, 2017: Merit Medical Announces Appointment of New Director 150
  • 6.22 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 150
  • 6.23 May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect's Advisory Board 153
  • 6.24 May 16, 2017: Charles J. Dockendorff Elected to Hologic Board of Directors 154
  • 6.25 May 11, 2017: Healthcare Veteran John Fletcher Joins MRI Interventions' Board of Directors 154
  • 6.26 May 03, 2017: Coloplast delivers satisfactory Q2 result 155
  • 6.27 May 02, 2017: iCAD Reports First-quarter 2017 Financial Results 156
  • 6.28 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 157
  • 6.29 Apr 27, 2017: Varian Spotlights World-Leading Systems for Advanced Radiotherapy, Radiosurgery, Brachytherapy and Proton Therapy at ESTRO 36 158
  • 6.30 Apr 27, 2017: Boston Scientific Announces Results For First Quarter 2017 159
  • 6.31 Apr 27, 2017: MRI Interventions Announces 2017 First Quarter Results 160
  • 6.32 Apr 27, 2017: Merit Medical Reports Results for First Quarter of 2017 162
  • 6.33 Apr 26, 2017: Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2017 163
  • 6.34 Apr 25, 2017: Stryker reports first quarter 2017 results 164
  • 6.35 Apr 23, 2017: Bard Announces First Quarter Results 165
  • 6.36 Apr 19, 2017: Mauna Kea Technologies Reports First Quarter 2017 Sales 166
  • 6.37 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 167
  • 6.38 Apr 06, 2017: MRI Interventions Announces Record Quarterly Revenue, Record ClearPoint System Procedures in 2017 First Quarter 167
  • 6.39 Apr 05, 2017: Varian Medical Systems Names New CFO 168
  • 6.40 Apr 04, 2017: Varian Medical Systems Establishes Direct Operation in South Africa 168
  • 6.41 Apr 03, 2017: Varian Medical Systems and Elekta Settle Patent Litigation 169
  • 6.42 Apr 03, 2017: Endomag Strengthens Board with Key Appointment 169
  • 6.43 Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 169
  • 6.44 Mar 13, 2017: Mauna Kea Appoints Jennifer F. Tseng, M.D. to Board of Directors 171
  • 6.45 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 171
  • 6.46 Mar 08, 2017: iCAD Reports Fourth Quarter and Full Year 2016 Financial Results 172
  • 6.47 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 174
  • 6.48 Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect's Board of Directors 175
  • 6.49 Mar 02, 2017: Mauna Kea Technologies: Superiority of Endomicroscopy for the Diagnosis of Gastric Cancer Highlighted in a Peer-Reviewed Publication Comparing Advanced Imaging Technologies 175
  • 6.50 Mar 01, 2017: Jose Baselga and Jean-Luc Butel Appointed to Board of Directors of Varian Medical Systems 176
  • 6.51 Mar 01, 2017: Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 176
  • 6.52 Feb 28, 2017: MRI Interventions Announces 2016 Fourth Quarter and Full Year Results 177
  • 6.53 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 180
  • 6.54 Feb 21, 2017: Merit Medical Reports Results for Fourth Quarter and Year Ended December 31, 2016 183
  • 6.55 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 184
  • 6.56 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 185
  • 6.57 Feb 02, 2017: Coloplast delivers Satisfactory Q1 Interim Results in Line with Guidance 186
  • 6.58 Feb 02, 2017: Boston Scientific Announces Results For Fourth Quarter And Full Year Ended December 31, 2016 187
  • 6.59 Feb 01, 2017: Hologic Announces Financial Results for First Quarter of Fiscal 2017 188
  • 6.60 Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 190
  • 6.61 Jan 30, 2017: Varian Announces Successful Separation of Imaging Components Business 190
  • 6.62 Jan 26, 2017: Bard Announces Fourth Quarter Results 190
  • 6.63 Jan 25, 2017: Varian Medical Systems Reports Results for First Quarter of Fiscal Year 2017 191
  • 6.64 Jan 24, 2017: Stryker reports 2016 results and 2017 outlook 193
  • 6.65 Jan 24, 2017: MRI Interventions Announces Year-End Update, Including 2016 Fourth Quarter and Full Year Revenues 194
  • 6.66 Jan 20, 2017: New 'smart needle' to make brain surgery safer 195
  • 6.67 Jan 10, 2017: Stryker provides 2016 preliminary net sales results 196
  • 6.68 Jan 09, 2017: Cardinal Health Reaches Settlement With West Virginia 198
  • 6.69 Jan 04, 2017: Hologic Appoints President of EMEA and Canada, Completing International Leadership Team 198
  • 6.70 Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 199

7 Appendix 231

  • 7.1 Methodology 231
  • 7.2 About GlobalData 234
  • 7.3 Contact Us 234
  • 7.4 Disclaimer 234

List of Tables

1.1 List of Tables

  • Table 1: Biopsy Devices - Pipeline Products by Stage of Development 16
  • Table 2: Biopsy Devices - Pipeline Products by Segment 17
  • Table 3: Biopsy Devices - Pipeline Products by Territory 18
  • Table 4: Biopsy Devices - Pipeline Products by Regulatory Path 19
  • Table 5: Biopsy Devices - Pipeline Products by Estimated Approval Date 20
  • Table 6: Biopsy Devices - Ongoing Clinical Trials 21
  • Table 7: Biopsy Devices Companies - Pipeline Products by Stage of Development 22
  • Table 8: Biopsy Devices - Pipeline Products by Stage of Development 25
  • Table 9: Actuated Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 28
  • Table 10: OsteoAccess - Product Status 28
  • Table 11: OsteoAccess - Product Description 28
  • Table 12: Arch Medical Devices Ltd Pipeline Products & Ongoing Clinical Trials Overview 29
  • Table 13: ARCH Pancreatic Lateral Sampling Device - Product Status 29
  • Table 14: ARCH Pancreatic Lateral Sampling Device - Product Description 29
  • Table 15: ARCH Prostate Transurethral Lateral Sampling Device - Product Status 30
  • Table 16: ARCH Prostate Transurethral Lateral Sampling Device - Product Description 30
  • Table 17: ARCH Pulmonary Lateral Sampling Device - Product Status 30
  • Table 18: ARCH Pulmonary Lateral Sampling Device - Product Description 31
  • Table 19: Boston University Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 20: Breast Biopsy Clip - Product Status 32
  • Table 21: Breast Biopsy Clip - Product Description 32
  • Table 22: Breast Biopsy Introducer - Product Status 33
  • Table 23: Breast Biopsy Introducer - Product Description 33
  • Table 24: Fine Needle Aspiration Tool - Product Status 33
  • Table 25: Fine Needle Aspiration Tool - Product Description 33
  • Table 26: C. R. Bard Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 27: EnCor Mini - Product Status 34
  • Table 28: EnCor Mini - Product Description 34
  • Table 29: Marquee - Product Status 35
  • Table 30: Marquee - Product Description 35
  • Table 31: Minimally Invasive Cutting Instrumentation - Product Status 35
  • Table 32: Minimally Invasive Cutting Instrumentation - Product Description 36
  • Table 33: Carlos III Health Institute Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 34: Automated Skin Biopsy Device - Product Status 37
  • Table 35: Automated Skin Biopsy Device - Product Description 37
  • Table 36: CleveX, Inc. Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 37: ClearVu Punch Biopsy - Product Status 38
  • Table 38: ClearVu Punch Biopsy - Product Description 38
  • Table 39: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 40: Inner Ear Fluid Aspirator - Product Status 39
  • Table 41: Inner Ear Fluid Aspirator - Product Description 39
  • Table 42: OCT- Assisted Endomyocardial Biopsy Catheter - Product Status 40
  • Table 43: OCT- Assisted Endomyocardial Biopsy Catheter - Product Description 40
  • Table 44: Control Medical Technology LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 45: 30ml ASPIRE 1 SPIN 170 - Product Status 41
  • Table 46: 30ml ASPIRE 1 SPIN 170 - Product Description 41
  • Table 47: 30ml ASPIRE 1 SPIN 90 - Product Status 42
  • Table 48: 30ml ASPIRE 1 SPIN 90 - Product Description 42
  • Table 49: 30ml ASPIRE 2 SPIN 170 - Product Status 42
  • Table 50: 30ml ASPIRE 2 SPIN 170 - Product Description 42
  • Table 51: 30ml ASPIRE 2 SPIN 90 - Product Status 43
  • Table 52: 30ml ASPIRE 2 SPIN 90 - Product Description 43
  • Table 53: 30ml ASPIRE Aspirator - Product Status 43
  • Table 54: 30ml ASPIRE Aspirator - Product Description 43
  • Table 55: ASPIRE Rotational Vacuum-Assisted Biopsy - Product Status 44
  • Table 56: ASPIRE Rotational Vacuum-Assisted Biopsy - Product Description 44
  • Table 57: Crux Medical Innovations Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 58: Multiple Core Biopsy Device - Product Status 45
  • Table 59: Multiple Core Biopsy Device - Product Description 45
  • Table 60: CuraMedical BV Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 61: Cytec Fine Needle Biopsy Device - Product Status 46
  • Table 62: Cytec Fine Needle Biopsy Device - Product Description 46
  • Table 63: Dartmouth College Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 64: Electrical Impedance Sensing Biopsy Sampling Device - Product Status 47
  • Table 65: Electrical Impedance Sensing Biopsy Sampling Device - Product Description 47
  • Table 66: Dune Medical Devices Ltd. Pipeline Products & Ongoing Clinical Trials Overview 48
  • Table 67: Soft Tissue Biopsy System - Breast Cancer - Product Status 48
  • Table 68: Soft Tissue Biopsy System - Breast Cancer - Product Description 48
  • Table 69: Emory University Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 70: 3D Ultrasound Guided Biopsy System - Product Status 49
  • Table 71: 3D Ultrasound Guided Biopsy System - Product Description 49
  • Table 72: Endomagnetics Inc. Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 73: Sienna+ - Product Status 50
  • Table 74: Sienna+ - Product Description 50
  • Table 75: Endomagnetics Inc. - Ongoing Clinical Trials Overview 51
  • Table 76: Sienna+ - Feasibility of Sentinel Lymph Node Biopsy in Rectal Cancer 52
  • Table 77: Sienna+ - Sentimag Along with Routine Technique in Detection of Sentinel Node Biopsy: SMART Study) 52
  • Table 78: Sienna+ - Sienna+ Injection Time Study: A Prospective Multicentre, Controlled Clinical Trial to Evaluate the Performance of Superparamagnetic Iron Oxide Vs. Standard Technique as Tracer in Sentinel Node Biopsy 52
  • Table 79: EP Global Communications, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
  • Table 80: EP Global Biopsy Device - Product Status 53
  • Table 81: EP Global Biopsy Device - Product Description 53
  • Table 82: Gamma Medica Inc Pipeline Products & Ongoing Clinical Trials Overview 54
  • Table 83: LumaGUIDE Biopsy Device - Product Status 54
  • Table 84: LumaGUIDE Biopsy Device - Product Description 54
  • Table 85: Harvard University Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 86: LSS Probe - Pancreatic Cancer - Product Status 55
  • Table 87: LSS Probe - Pancreatic Cancer - Product Description 55
  • Table 88: Hologic Inc Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 89: Brevera Biopsy System - Product Status 56
  • Table 90: Brevera Biopsy System - Product Description 56
  • Table 91: iCAD Inc Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 92: MRI-Guided Prostate Biopsy - Product Status 57
  • Table 93: MRI-Guided Prostate Biopsy - Product Description 57
  • Table 94: Prostate MRI/TRUS-Fusion Device - Product Status 58
  • Table 95: Prostate MRI/TRUS-Fusion Device - Product Description 58
  • Table 96: Icahn School of Medicine at Mount Sinai Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 97: Tissue Sampling Tool - Product Status 59
  • Table 98: Tissue Sampling Tool - Product Description 59
  • Table 99: Indian Institute of Technology Bombay Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 100: Reusable Biopsy Gun - Product Status 60
  • Table 101: Reusable Biopsy Gun - Product Description 60
  • Table 102: Indio Labs Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 103: BioScoop Biopsy System - Product Status 61
  • Table 104: BioScoop Biopsy System - Product Description 61
  • Table 105: BxSeal System - Product Status 62
  • Table 106: BxSeal System - Product Description 62
  • Table 107: Innobreeze Communication Technologies Private Limited Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 108: BreezeScan - Product Status 63
  • Table 109: BreezeScan - Product Description 63
  • Table 110: BreezeScan - Cervical Cancer - Product Status 64
  • Table 111: BreezeScan - Cervical Cancer - Product Description 64
  • Table 112: Institute of Cancer Research Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 113: Tissue Microarray Sample Cutter - Product Status 65
  • Table 114: Tissue Microarray Sample Cutter - Product Description 65
  • Table 115: Intelligent Fiber Optic Systems Corporation Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 116: MEDIFOS - MRI Compatible Needle System - Product Status 66
  • Table 117: MEDIFOS - MRI Compatible Needle System - Product Description 66
  • Table 118: John Hopkins University Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 119: Cryoprobe Capsule - Product Status 67
  • Table 120: Cryoprobe Capsule - Product Description 67
  • Table 121: Integrated Punch Biopsy Kit - Product Status 68
  • Table 122: Integrated Punch Biopsy Kit - Product Description 68
  • Table 123: Robot-guided Prostate Biopsy Probe - Product Status 68
  • Table 124: Robot-guided Prostate Biopsy Probe - Product Description 68
  • Table 125: Skin Biopsy Device - Product Status 69
  • Table 126: Skin Biopsy Device - Product Description 69
  • Table 127: Transrectal Prostate Biopsy Device - Product Status 69
  • Table 128: Transrectal Prostate Biopsy Device - Product Description 69
  • Table 129: LX Medical Corp Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 130: OCT Catheter - Product Status 70
  • Table 131: OCT Catheter - Product Description 70
  • Table 132: Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 133: IVLCM Capsule - Product Status 71
  • Table 134: IVLCM Capsule - Product Description 71
  • Table 135: Mayo Clinic US Pipeline Products & Ongoing Clinical Trials Overview 72
  • Table 136: Full Thickness Gastric Biopsy Needle - Product Status 72
  • Table 137: Full Thickness Gastric Biopsy Needle - Product Description 72
  • Table 138: Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 139: Corvocet Biopsy System - Product Status 73
  • Table 140: Corvocet Biopsy System - Product Description 74
  • Table 141: MI4 Spine, LLC Pipeline Products & Ongoing Clinical Trials Overview 75
  • Table 142: Bone harvesting device - Product Status 75
  • Table 143: Bone harvesting device - Product Description 75
  • Table 144: MRI Interventions Inc Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 145: MRI-safe Myocardial Biopsy Forcep - Product Status 76
  • Table 146: MRI-safe Myocardial Biopsy Forcep - Product Description 76
  • Table 147: NeoDynamics AB Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 148: Cytotest - Product Status 77
  • Table 149: Cytotest - Product Description 77
  • Table 150: Fourier/AS - Product Status 78
  • Table 151: Fourier/AS - Product Description 78
  • Table 152: Neonavia Second Generation Biopsy Device - Product Status 78
  • Table 153: Neonavia Second Generation Biopsy Device - Product Description 79
  • Table 154: Precision Biopsy Llc Pipeline Products & Ongoing Clinical Trials Overview 80
  • Table 155: ClariCore Biopsy System - Product Status 80
  • Table 156: ClariCore Biopsy System - Product Description 80
  • Table 157: Precision Biopsy Llc - Ongoing Clinical Trials Overview 81
  • Table 158: ClariCore Biopsy System - Clinical Trial of ClariCore Biopsy System in Prostate Cancer Patients 82
  • Table 159: ClariCore Biopsy System - Prospective, Multi-center Study of the Claricore Optical Biopsy System in Patients Undergoing Radical Retropubic Prostatectomy for Prostate Tissue Classification Algorithm Development 82
  • Table 160: ClariCore Biopsy System - Prospective, Multi-Center Study of the ClariCore Optical Biopsy System in Patients Undergoing TRUS-Guided Prostrate Biopsy With or Without MR Fusion For Prostrate Tissue Classification Algorithm Development 82
  • Table 161: Quality ElectroDynamics, LLC Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 162: RF Breast-Coil-Biopsy-Plate System - Product Status 83
  • Table 163: RF Breast-Coil-Biopsy-Plate System - Product Description 83
  • Table 164: Rambam Health Care Campus Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 165: InstaFan - Fina Needle Aspiration - Product Status 84
  • Table 166: InstaFan - Fina Needle Aspiration - Product Description 84
  • Table 167: Robopsy Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 168: Robopsy System - Product Status 85
  • Table 169: Robopsy System - Product Description 85
  • Table 170: Rutgers The State University of New Jersey Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 171: Vascular Access Needle Assembly - Product Status 86
  • Table 172: Vascular Access Needle Assembly - Product Description 86
  • Table 173: Sanovas Inc Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 174: Transbronchial Pressure Vacuum Actuated (TPVA) Micro Biopsy Capsule - Product Status 87
  • Table 175: Transbronchial Pressure Vacuum Actuated (TPVA) Micro Biopsy Capsule - Product Description 87
  • Table 176: SpectraScience Inc Pipeline Products & Ongoing Clinical Trials Overview 88
  • Table 177: a/LCI System - Product Status 88
  • Table 178: a/LCI System - Product Description 89
  • Table 179: Next Generation Multi-Modal Fluorescence And Broadband Spectroscopy System - Product Status 89
  • Table 180: Next Generation Multi-Modal Fluorescence And Broadband Spectroscopy System - Product Description 89
  • Table 181: WavSTAT - Esophageal Cancer - Product Status 90
  • Table 182: WavSTAT - Esophageal Cancer - Product Description 90
  • Table 183: WavSTAT - Inflammatory Bowel Syndrome - Product Status 90
  • Table 184: WavSTAT - Inflammatory Bowel Syndrome - Product Description 91
  • Table 185: WavSTAT - Lung Cancer - Product Status 91
  • Table 186: WavSTAT - Lung Cancer - Product Description 91
  • Table 187: WavSTAT - Pancreatic Cancer - Product Status 92
  • Table 188: WavSTAT - Pancreatic Cancer - Product Description 92
  • Table 189: WavSTAT 4 System - Colon Cancer - Product Status 92
  • Table 190: WavSTAT 4 System - Colon Cancer - Product Description 93
  • Table 191: WavSTAT4 Optical Biopsy System - Product Status 93
  • Table 192: WavSTAT4 Optical Biopsy System - Product Description 93
  • Table 193: SpectraScience Inc - Ongoing Clinical Trials Overview 94
  • Table 194: WavSTAT4 Optical Biopsy System - Multicenter, Open, Prospective Study on Modified Resect and DIscard Strategy of Small Colonic Lesions Using WavSTAT4 Optical Biopsy System: The MORDIS Study Clinical Investigational Plan 95
  • Table 195: Taewoong Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 96
  • Table 196: Optimos Biopsy Forcep - Product Status 96
  • Table 197: Optimos Biopsy Forcep - Product Description 96
  • Table 198: The University of Adelaide Pipeline Products & Ongoing Clinical Trials Overview 97
  • Table 199: Smart Needle - Product Status 97
  • Table 200: Smart Needle - Product Description 97
  • Table 201: Tufts University Pipeline Products & Ongoing Clinical Trials Overview 98
  • Table 202: INFORCE Biopsy Device - Product Status 98
  • Table 203: INFORCE Biopsy Device - Product Description 98
  • Table 204: UC Care Ltd Pipeline Products & Ongoing Clinical Trials Overview 99
  • Table 205: ThermoDirect BPH System - Product Status 99
  • Table 206: ThermoDirect BPH System - Product Description 99
  • Table 207: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 100
  • Table 208: PneumoGel - Product Status 100
  • Table 209: PneumoGel - Product Description 100
  • Table 210: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 101
  • Table 211: Muscle Biopsy Clamp - Product Status 101
  • Table 212: Muscle Biopsy Clamp - Product Description 101
  • Table 213: University of California San Francisco Pipeline Products & Ongoing Clinical Trials Overview 102
  • Table 214: Safe Endovascular Biospy Device - Product Status 102
  • Table 215: Safe Endovascular Biospy Device - Product Description 102
  • Table 216: University of Cambridge Pipeline Products & Ongoing Clinical Trials Overview 103
  • Table 217: CAMPROBE - Product Status 103
  • Table 218: CAMPROBE - Product Description 103
  • Table 219: University of Cambridge - Ongoing Clinical Trials Overview 104
  • Table 220: CAMPROBE - Developing a Safer and More Accurate Device for Biopsies of Suspected Prostate Cancer 105
  • Table 221: University of Florida Pipeline Products & Ongoing Clinical Trials Overview 106
  • Table 222: Coaxial Biopsy Needle - Product Status 106
  • Table 223: Coaxial Biopsy Needle - Product Description 106
  • Table 224: University of Leicester Pipeline Products & Ongoing Clinical Trials Overview 107
  • Table 225: Universal Tissue Sampling Device - Product Status 107
  • Table 226: Universal Tissue Sampling Device - Product Description 107
  • Table 227: University of Louisville Pipeline Products & Ongoing Clinical Trials Overview 108
  • Table 228: Suction Assisted Multiple Biopsy Device - Product Status 108
  • Table 229: Suction Assisted Multiple Biopsy Device - Product Description 108
  • Table 230: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 109
  • Table 231: Fine Aspiration Biopsy Needle - Product Status 109
  • Table 232: Fine Aspiration Biopsy Needle - Product Description 109
  • Table 233: Renal Biopsy Device - Product Status 110
  • Table 234: Renal Biopsy Device - Product Description 110
  • Table 235: Skin Tissue Biopsy Device - Product Status 110
  • Table 236: Skin Tissue Biopsy Device - Product Description 111
  • Table 237: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview 112
  • Table 238: Intracranial Endoscopy System - Product Status 112
  • Table 239: Intracranial Endoscopy System - Product Description 112
  • Table 240: Needle Placement System - Product Status 113
  • Table 241: Needle Placement System - Product Description 113
  • Table 242: University of Missouri Pipeline Products & Ongoing Clinical Trials Overview 114
  • Table 243: Needle Aspiration Device - Product Status 114
  • Table 244: Needle Aspiration Device - Product Description 114
  • Table 245: University of Queensland Pipeline Products & Ongoing Clinical Trials Overview 115
  • Table 246: Micropunch - Product Status 115
  • Table 247: Micropunch - Product Description 115
  • Table 248: University of Texas at Austin Pipeline Products & Ongoing Clinical Trials Overview 116
  • Table 249: Optical Device - Skin Cancer - Product Status 116
  • Table 250: Optical Device - Skin Cancer - Product Description 116
  • Table 251: University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 117
  • Table 252: Mediastinal Needle Biopsy Device - Product Status 117
  • Table 253: Mediastinal Needle Biopsy Device - Product Description 117
  • Table 254: University of Washington Pipeline Products & Ongoing Clinical Trials Overview 118
  • Table 255: Endometrial Biopsy Device - Product Status 118
  • Table 256: Endometrial Biopsy Device - Product Description 118
  • Table 257: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview 119
  • Table 258: Core and Side Cut Biopsy Device - Product Status 119
  • Table 259: Core and Side Cut Biopsy Device - Product Description 119
  • Table 260: Vascular BioSciences Pipeline Products & Ongoing Clinical Trials Overview 120
  • Table 261: EABx - Lung Transplant Rejection - Product Status 120
  • Table 262: EABx - Lung Transplant Rejection - Product Description 120
  • Table 263: EABx - Pulmonary Hypertension - Product Status 121
  • Table 264: EABx - Pulmonary Hypertension - Product Description 121
  • Table 265: Verisante Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 122
  • Table 266: Verisante Core - Cervical Cancer - Product Status 122
  • Table 267: Verisante Core - Cervical Cancer - Product Description 123
  • Table 268: Verisante Core - Gastrointestinal Cancer - Product Status 123
  • Table 269: Verisante Core - Gastrointestinal Cancer - Product Description 123
  • Table 270: Verisante Core - Lung Cancer - Product Status 124
  • Table 271: Verisante Core - Lung Cancer - Product Description 124
  • Table 272: Verisante Core - Nasopharnygeal Cancer - Product Status 124
  • Table 273: Verisante Core - Nasopharnygeal Cancer - Product Description 125
  • Table 274: VitruMed Inc. Pipeline Products & Ongoing Clinical Trials Overview 126
  • Table 275: RF Tissue Welding Device - Product Status 126
  • Table 276: RF Tissue Welding Device - Product Description 126
  • Table 277: Yale University Pipeline Products & Ongoing Clinical Trials Overview 127
  • Table 278: Painless Bone Biopsy Needle - Product Status 127
  • Table 279: Painless Bone Biopsy Needle - Product Description 127
  • Table 280: ZAMAR S.r.l. Pipeline Products & Ongoing Clinical Trials Overview 128
  • Table 281: Evocut Needle - Product Status 128
  • Table 282: Evocut Needle - Product Description 128
  • Table 283: Glossary 233

List of Figures

1.2 List of Figures

  • Figure 1: Biopsy Devices - Pipeline Products by Stage of Development 16
  • Figure 2: Biopsy Devices - Pipeline Products by Segment 17
  • Figure 3: Biopsy Devices - Pipeline Products by Territory 18
  • Figure 4: Biopsy Devices - Pipeline Products by Regulatory Path 19
  • Figure 5: Biopsy Devices - Pipeline Products by Estimated Approval Date 20
  • Figure 6: Biopsy Devices - Ongoing Clinical Trials 21
Back to Top